Advanced or Metastatic Solid Tumor Terminated Phase 1 Trials for Spartalizumab (DB14892)

Also known as: Advanced / Metastatic Solid Tumor / Advanced/Metastatic Solid Tumor / Advanced and Metastatic Solid Tumor / Metastatic and Advanced Solid Tumors / Advanced and/or Metastatic Solid Tumors / Advanced or Metastatic Solid Tumors / Advanced / Metastatic Solid Tumors / Advanced/ Metastatic Solid Tumors / Advanced/Metastatic Solid Tumors

IndicationStatusPhase
DBCOND0109909 (Advanced or Metastatic Solid Tumor)Terminated1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02452268A Phase I/Ib Study of NIZ985 in Combination With PDR001 in Adults With Metastatic CancersTreatment